HEOR Staff Writer

Clinical evidence shows that AposHealth (an FDA-cleared medical device) impro...

Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Go...

Zambia’s National Health Insurance Making Progress Towards Strategic Pu...

Chronic Heart Failure: PBAC Recommends Empagliflozin

Iberian Healthcare Collaboration: Spain & Portugal Unite for Health Tech...

Global Pull Incentive Needed to Future-Proof Antibiotic Innovation, Says OHE ...